Novartis Wins FDA Nod for CDK4/6 Inhibitor for Certain Breast Cancers

From MedPage Today OB/Gyn
March 13, 2017 - 4:35pm
(MedPage Today) -- Ribociclib (Kisqali) OK'd in combination with aromatase inhibitor


Continue reading this article »